283 related articles for article (PubMed ID: 27535619)
1. Pharmacological targeting of kinases MST1 and MST2 augments tissue repair and regeneration.
Fan F; He Z; Kong LL; Chen Q; Yuan Q; Zhang S; Ye J; Liu H; Sun X; Geng J; Yuan L; Hong L; Xiao C; Zhang W; Sun X; Li Y; Wang P; Huang L; Wu X; Ji Z; Wu Q; Xia NS; Gray NS; Chen L; Yun CH; Deng X; Zhou D
Sci Transl Med; 2016 Aug; 8(352):352ra108. PubMed ID: 27535619
[TBL] [Abstract][Full Text] [Related]
2. Pharmacological inhibition of Hippo pathway, with the novel kinase inhibitor XMU-MP-1, protects the heart against adverse effects during pressure overload.
Triastuti E; Nugroho AB; Zi M; Prehar S; Kohar YS; Bui TA; Stafford N; Cartwright EJ; Abraham S; Oceandy D
Br J Pharmacol; 2019 Oct; 176(20):3956-3971. PubMed ID: 31328787
[TBL] [Abstract][Full Text] [Related]
3. The Hippo Signaling Pathway in Regenerative Medicine.
Hong L; Li Y; Liu Q; Chen Q; Chen L; Zhou D
Methods Mol Biol; 2019; 1893():353-370. PubMed ID: 30565146
[TBL] [Abstract][Full Text] [Related]
4. Treatment with Mammalian Ste-20-like Kinase 1/2 (MST1/2) Inhibitor XMU-MP-1 Improves Glucose Tolerance in Streptozotocin-Induced Diabetes Mice.
Faizah Z; Amanda B; Ashari FY; Triastuti E; Oxtoby R; Rahaju AS; Aziz MA; Lusida MI; Oceandy D
Molecules; 2020 Sep; 25(19):. PubMed ID: 32987643
[TBL] [Abstract][Full Text] [Related]
5. XMU-MP-1 protects heart from ischemia/reperfusion injury in mice through modulating Mst1/AMPK pathway.
Liu Y; Chu G; Shen W; Zhang Y; Xu W; Yu Y
Eur J Pharmacol; 2022 Mar; 919():174801. PubMed ID: 35123978
[TBL] [Abstract][Full Text] [Related]
6. Impaired liver regeneration in aged mice can be rescued by silencing Hippo core kinases MST1 and MST2.
Loforese G; Malinka T; Keogh A; Baier F; Simillion C; Montani M; Halazonetis TD; Candinas D; Stroka D
EMBO Mol Med; 2017 Jan; 9(1):46-60. PubMed ID: 27940445
[TBL] [Abstract][Full Text] [Related]
7. Treatment with XMU-MP-1 erases hyperglycaemic memory in hearts of diabetic mice.
Zhang Z; Si YF; Hu W; Yan P; Yu Y
Biochem Pharmacol; 2021 Jun; 188():114574. PubMed ID: 33887258
[TBL] [Abstract][Full Text] [Related]
8. Angiotensin-converting enzyme 2 activation suppresses pulmonary vascular remodeling by inducing apoptosis through the Hippo signaling pathway in rats with pulmonary arterial hypertension.
Yan D; Li G; Zhang Y; Liu Y
Clin Exp Hypertens; 2019; 41(6):589-598. PubMed ID: 30806090
[No Abstract] [Full Text] [Related]
9. Mammalian Mst1 and Mst2 kinases play essential roles in organ size control and tumor suppression.
Song H; Mak KK; Topol L; Yun K; Hu J; Garrett L; Chen Y; Park O; Chang J; Simpson RM; Wang CY; Gao B; Jiang J; Yang Y
Proc Natl Acad Sci U S A; 2010 Jan; 107(4):1431-6. PubMed ID: 20080598
[TBL] [Abstract][Full Text] [Related]
10. MST1/2 inhibitor XMU-MP-1 alleviates the injury induced by ionizing radiation in haematopoietic and intestinal system.
Zhou X; Wang H; Li D; Song N; Yang F; Xu W
J Cell Mol Med; 2022 Mar; 26(5):1621-1628. PubMed ID: 35088536
[TBL] [Abstract][Full Text] [Related]
11. A non-covalent inhibitor XMU-MP-3 overrides ibrutinib-resistant Btk
Gui F; Jiang J; He Z; Li L; Li Y; Deng Z; Lu Y; Wu X; Chen G; Su J; Song S; Zhang YM; Yun CH; Huang X; Weisberg E; Zhang J; Deng X
Br J Pharmacol; 2019 Dec; 176(23):4491-4509. PubMed ID: 31364164
[TBL] [Abstract][Full Text] [Related]
12. Radix Scrophulariae Extracts Exert Effect on Hyperthyroidism via MST1/Hippo Signaling Pathway.
Zhang N; Ye T; Lu X; Li ZH; Li L
Chin J Integr Med; 2023 Nov; 29(11):998-1006. PubMed ID: 37661231
[TBL] [Abstract][Full Text] [Related]
13. XMU-MP-1 induces growth arrest in a model human mini-organ and antagonises cell cycle-dependent paclitaxel cytotoxicity.
Mitchell E; Mellor CEL; Purba TS
Cell Div; 2020; 15():11. PubMed ID: 32973917
[TBL] [Abstract][Full Text] [Related]
14. Hippo signaling is a potent in vivo growth and tumor suppressor pathway in the mammalian liver.
Lu L; Li Y; Kim SM; Bossuyt W; Liu P; Qiu Q; Wang Y; Halder G; Finegold MJ; Lee JS; Johnson RL
Proc Natl Acad Sci U S A; 2010 Jan; 107(4):1437-42. PubMed ID: 20080689
[TBL] [Abstract][Full Text] [Related]
15. XMU-MP-1 attenuates osteoarthritis via inhibiting cartilage degradation and chondrocyte apoptosis.
Hao X; Zhao J; Jia L; He T; Wang H; Fan J; Yang Y; Su F; Lu Q; Zheng C; Yang L; Jie Q
Front Bioeng Biotechnol; 2022; 10():998077. PubMed ID: 36199358
[TBL] [Abstract][Full Text] [Related]
16. MST1 selective inhibitor Xmu-mp-1 ameliorates neuropathological changes in a rat model of sporadic Alzheimer's Disease by modulating Hippo-Wnt signaling crosstalk.
Sahu MR; Ahmad MH; Mondal AC
Apoptosis; 2024 May; ():. PubMed ID: 38760516
[TBL] [Abstract][Full Text] [Related]
17. Mst1/2 Kinases Inhibitor, XMU-MP-1, Attenuates Angiotensin II-Induced Ascending Aortic Expansion in Hypercholesterolemic Mice.
Okuyama M; Jiang W; Yang L; Subramanian V
Circ Rep; 2021 Apr; 3(5):259-266. PubMed ID: 34007939
[No Abstract] [Full Text] [Related]
18. MOBKL1A/MOBKL1B phosphorylation by MST1 and MST2 inhibits cell proliferation.
Praskova M; Xia F; Avruch J
Curr Biol; 2008 Mar; 18(5):311-21. PubMed ID: 18328708
[TBL] [Abstract][Full Text] [Related]
19. The MEK-ERK-MST1 Axis Potentiates the Activation of the Extrinsic Apoptotic Pathway during GDC-0941 Treatment in Jurkat T Cells.
Nováková J; Talacko P; Novák P; Vališ K
Cells; 2019 Feb; 8(2):. PubMed ID: 30795621
[TBL] [Abstract][Full Text] [Related]
20. Hippo/Yap signaling controls epithelial progenitor cell proliferation and differentiation in the embryonic and adult lung.
Lange AW; Sridharan A; Xu Y; Stripp BR; Perl AK; Whitsett JA
J Mol Cell Biol; 2015 Feb; 7(1):35-47. PubMed ID: 25480985
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
